MetLife Investment Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-2,000
| Closed | -$633K | – | 2838 |
|
|
2023
Q4 | $633K | Sell |
2,000
-28
| -1% | -$8.86K | ﹤0.01% | 1552 |
|
|
2023
Q3 | $343K | Hold |
2,028
| – | – | ﹤0.01% | 1858 |
|
|
2023
Q2 | $440K | Sell |
2,028
-15,011
| -88% | -$3.26M | ﹤0.01% | 1780 |
|
|
2023
Q1 | $3.09M | Buy |
17,039
+1,227
| +8% | +$223K | 0.02% | 719 |
|
|
2022
Q4 | $3.11M | Hold |
15,812
| – | – | 0.02% | 713 |
|
|
2022
Q3 | $3.56M | Buy |
15,812
+2,146
| +16% | +$483K | 0.03% | 591 |
|
|
2022
Q2 | $1.73M | Buy |
13,666
+1,367
| +11% | +$173K | 0.01% | 952 |
|
|
2022
Q1 | $1.56M | Buy |
12,299
+4,297
| +54% | +$545K | 0.01% | 1098 |
|
|
2021
Q4 | $1.05M | Hold |
8,002
| – | – | 0.01% | 1111 |
|
|
2021
Q3 | $979K | Hold |
8,002
| – | – | 0.01% | 1126 |
|
|
2021
Q2 | $912K | Buy |
8,002
+1,987
| +33% | +$226K | 0.01% | 1222 |
|
|
2021
Q1 | $723K | Sell |
6,015
-899
| -13% | -$108K | 0.01% | 1310 |
|
|
2020
Q4 | $702K | Hold |
6,914
| – | – | 0.01% | 1297 |
|
|
2020
Q3 | $535K | Hold |
6,914
| – | – | 0.01% | 1335 |
|
|
2020
Q2 | $771K | Buy |
6,914
+2,279
| +49% | +$254K | 0.01% | 1143 |
|
|
2020
Q1 | $334K | Buy |
4,635
+2,361
| +104% | +$170K | ﹤0.01% | 1435 |
|
|
2019
Q4 | $171K | Buy |
+2,274
| New | +$171K | ﹤0.01% | 2061 |
|